Status of Surgical Management of Borderline Ovarian Tumors in France: are Recommendations Being Followed? Multicentric French Study by the FRANCOGYN Group.
Fiche publication
Date publication
avril 2021
Journal
Annals of surgical oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr COUTANT Charles, Dr DEMARCHI Martin, Dr GANTZER Justine
Tous les auteurs :
Lecointre L, Bund V, Sangnier E, Ouldamer L, Bendifallah S, Koskas M, Bolze PA, Collinet P, Canlorbe G, Touboul C, Huchon C, Coutant C, Faller E, Boisramé T, Gantzer J, Demarchi M, Lavoué V, Akladios C
Lien Pubmed
Résumé
Borderline ovarian tumors (BOTs) are tumors with a favorable prognosis but whose management by consensus is essential to limit the risk of invasive recurrence. This study aimed to conduct an inventory of surgical practices for BOT in France and to evaluate the conformity of the treatment according to the current French guidelines.
Référence
Ann Surg Oncol. 2021 Apr 26;: